<scp>scRNA</scp> ‐Seq reveals anti‐lymphoma immune responses in mogamulizumab‐associated skin eruptions
Our study provides novel insights into the molecular properties of residual malignant clones within MAR that appear silenced, surrounded by a putatively anti-tumor immune response.
Authors
- S. Meehan (ORCID: https://orcid.org/0000-0001-9055-5576)
- Grace M. Christensen (ORCID: https://orcid.org/0000-0003-0265-1416)
- Jonah Shulman
- Natalia Alkon (ORCID: https://orcid.org/0000-0002-0336-5318)
- Jónas A. Aðalsteinsson (ORCID: https://orcid.org/0000-0002-1159-6159)
- Patrick M. Brunner (ORCID: https://orcid.org/0000-0002-3488-3345)
- Emry R. Cohenour
- Agata Kurowski (ORCID: https://orcid.org/0000-0003-0502-571X)
- Sumanth Chennareddy (ORCID: https://orcid.org/0000-0002-3289-0592)
- Constanze Jonak (ORCID: https://orcid.org/0000-0002-2347-436X)
- Malini P. Naidu
- Shannon Meledathu
- L.R. Port
- Nicholas Gulati
Institutions
- Mount Sinai Hospital (US)
- Tisch Hospital (US)
- Medical University of Vienna (AT)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1111/jdv.70154
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00